Market Highlights

Eye care has become one of the important aspects of medicine due to the continuous development of new therapies and availability of technologically advanced devices for eye care. Furthermore, the prevalence of eye disease is found to be increasing for all ages. Macular degeneration diseases such as Best disease and Stargardt disease are found to be highly prevalent among the children. Market players are now focusing on the development of novel therapies such as stem cell therapy to reduce the supply-demand gap in the market. Eye care supplement act as a protective measure whose demand is found to be increasing in the developing countries across the globe. Additionally, increasing demand for early diagnosis and treatment is boosting the market growth.

Global Juvenile Macular Degeneration (Stargardt Disease) market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.

Segmentation

The global juvenile macular degeneration (Stargardt Disease) market is segmented on the basis of diagnosis, devices and end users.

On the basis of diagnosis, the market is segmented into Fluroscein Angiography (FA), Fundus Autofluorescence (FAF), Optical Coherence Tomography (OCT), and Electroretinography (ERG).

On the basis of devices, the market is segmented into magnifying spectacles, magnifiers, reading telescope.

On the basis of end users, the market is segmented into hospitals & eye clinics, and research & academic institutes.

Key Players

Some of key the players in the market are Acucela Inc. (U.S.), Alkeus Pharmaceuticals Inc. (U.S.), Astellas Pharma Inc. (Japan), ProQR Therapeutics NV (Netherland), Sanofi (France), Bayer HealthCare (Germany), F. Hoffmann-La Roche (Switzerland), Copernicus Therapeutics Inc. (U.S.), Grupo Ferrer Internacional SA (U.S.), Iris Pharma (U.S.), Nemus Bioscience Inc (U.S.), Ophthotech Corp (U.S.), Iconic Therapeutics (U.S.), Adverum Biotechnologies (U.S.), PanOptica (U.S.), RXi Pharmaceuticals (U.S.), Neurotech Pharmaceuticals (U.S.)

Regional Analysis

The global juvenile macular degeneration market consists of four major regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.

America holds the largest market share in the juvenile macular degeneration market owing to increasing prevalence of eye diseases in the U.S. and Canada. Demand for eye care supplements, availability of specialty services further fuels the growth of the market. According to World Health Organization (WHO), in 2014, worldwide 285 million people were visually impaired in which 246 have low vision and 39 million are completely blind. Moreover, the North America region accounted for USD 163.23 Million in 2016.

The European juvenile macular degeneration market accounted for 32.7% market share in 2016. In Europe, Germany, the U.K, and France are the largest contributors to the market owing to the availability of funds for research, and extensive research and development activities in ophthalmology. The development of novel therapies and other treatment options for juvenile macular degeneration also fuel the growth of the market.

In Asia Pacific, India, and China are the fastest developing regions in the market owing to an overall demand for early diagnostic and treatment services, and increasing expenditure on primary care services across Asia Pacific. Rising awareness about degeneration among the children and available treatment options also influence the growth of the market. The growth of the market is also influenced by improvement in the delivery of care in the number of healthcare institutes such as hospitals, specialty clinics, diagnostic center, and others.

The Middle East & Africa exhibit steady but positive growth owing to low technology penetration in developing regions of Africa, and increasing demand for diagnostics services in developing regions. In the Middle East, the United Arab Emirates accounts for the largest market share for macular degeneration.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Remote Monitoring of Heart Diseases to Influence Global Cardiac Implants Market

Cardiac implants are medical devices implanted in the heart for monitoring and maintenance of normal functioning of the organ. They are used in the treatment of cardiac arrhythmia, myocardial infarction, and others. The global cardiac implants market report by Market Research Future (MRFR) looks at various developments in implants and the breakthroughs for keeping cardiovascular diseases at bay for the period of 2018 to 2023 (forecast period).

Market Scope

The global cardiac implants market can display a CAGR of 7.82% over the forecast period to touch a value of USD 38,054.3 million by 2023. Major factors driving the market growth are the large geriatric population and the prevalence of cardiovascular diseases. The elderly populace is susceptible to heart conditions due to aging and lead to coronary artery disease, atrial fibrillation, and others. According to the Center for Disease Control & Prevention (CDC), 2.7 to 6.1 million in the U.S. had atrial fibrillation in 2017.

But high costs of these implants and risks of these injections can hamper the market growth.

Segmentation

The global cardiac implants market has been segmented by device, indication, and end-user. By device, it is segmented into cardiac rhythm management devices, coronary stents, prosthetic heart valve devices, ventricular assist devices, implantable loop recorder/implantable cardiac monitor, and others.

By indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others.

On the basis of end-user, the market has been segmented into hospitals, cardiac care centers, ambulatory centers & home care, academic institutes, and others. The hospitals segment accounted for a market value of USD 8,721.6 million in 2017.

Regional Analysis

The global cardiac implants market, based on region, is divided into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

The Americas had dominated the market owing to the large prevalence of cardiovascular diseases in North America and adoption of cardiac implantable devices in hospitals. Development of wireless systems as well as a large healthcare expenditure for the masses in North America can positively impact the regional cardiac implants market growth. According to the American Heart Association, nearly 92.1 million adults in the U.S. had suffered a cardiac attack.

Europe can register a remarkable growth rate during the forecast period due to funds from the government and rise of reimbursement schemes for heart patients. Italy, in particular, had accounted for 9.9% share in 2017. Approval of new products by regulatory bodies can be a victory for manufacturers making them easier to bring it to market in the coming years. Recently, Abbott attained its approval for its implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator implants.

APAC can showcase a stellar growth rate during the forecast period owing to the large geriatric populace, cases of cardiovascular diseases, and rise of medical tourism. Regulatory approval of devices for artificial control on a person’s heartbeat can drive the regional cardiac implants market growth. High demand of products for rhythm management and prevention for stroke will bode well globally.

Lastly, the MEA region is accountable for the lowest market share due to the slow growth of economies.

Competition Outlook

Edwards Lifesciences Corporation, LivaNova PLC, B. Braun Melsungen AG, Amg International, Biotronik, SynCardia Systems, Inc., Boston Scientific Corporation, Medtronic Plc, Abbott, and Terumo Corporation are reputed players of the global cardiac implants market.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Market Insights:

Market Research Future (MRFR)’s latest study asserts that the global small molecule API market is set to expand at a CAGR of 7% during the forecast period 2016 to 2027. The global market is set to reach a value over USD 279.7 Mn by 2027. The increased investments in the research & findings coupled with government support are likely to propel the market growth in the forthcoming years.

The pharmaceutical industry is presently making massive profits and is equipped with developed infrastructure. The pharmaceutical industry is anticipated to expand in the foreseeable future. This, in turn, is expected to drive the growth of the small molecule API market. Additionally, the increase in the prevalence of diseases coupled with the discovery ofnew viruses and diseases is prognosticated to affect the small molecule API market proliferation positively.

Some of the factors responsible for favoring the expansion of the Small Molecule API Market size include growing demand for small molecule drugs, rising access to the medication in developing and underdeveloped countries, entry of big CMOs into the market, etc. Furthermore, rising burden of cardiovascular diseases and cancer is forecasted to intensify the competition among the players of the small molecule api manufacturing companies market. According to the American Cancer Society, 1,735,350 new cancer cases and 609,640 cancer deaths are estimatedin the U.S. alone.

Market Segmentation:

By type, the small molecule API market has been segmented into synthetic/chemical API, and biological API. Synthetic/chemical API segment currently holds 81.4% share of the market. It is likely to retain its pole position over the forecast period.

By application, the global small molecule API market is segmented into cardiovascular, oncology, diabetes, immunological disorders, and others. The cardiovascular segment held the maximum share of the market in 2015. It is anticipated to show positive growth across the review period.

By manufacturing method, the small molecule API market has been segmented into in-house and contract.

Competitive Dashboard:

Some of the key players profiled in the report are Albemarle Corporation, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, Lonza, Merck Sharp & Dohme Corp., Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG, Pfizer Inc., and Siegfried AG.

Regional Analysis:

By region, the global small molecule API market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America is the largest market for small molecule API. It is expected to retain a significant market share through the assessment period. The factors favoring the expansion of the regional market include developed healthcare sector, availability of funds, increasing clinical trials, rising burden of cancer, etc.

Europe is the second largest small molecule API market. It is estimated to exhibit healthy growth over the next few years. The growthis attributable to the initiatives undertaken by the governments to support the expansion oh pharmaceutical industry. Furthermore, the availability of funds coupled with the adoption of next-gen healthcare technology is anticipated to aid market proliferation in the region.

Asia Pacific is projected to thrive at the highest CAGR during the review period. The Asian countries have an abundance of raw materials required for drug manufacturing. Additionally, low labor cost and regulatory relaxations have aided profit maximization for the regional market players. Asia Pacific is one of the significant exporters of small molecule drug, andthe trend is projected to continue over the next few years.

The Middle East & Africa is set to exhibit steady growth. The African regions lack proper healthcare facilities and resonate strong growth opportunities. However, the Middle Eastern countries such as Qatar and Kuwait are expected to witness considerable growth due to the developedhealthcare sector and increasing awareness.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

CAGR Of 4.37% to Develop Autism Disorder and Treatment Market Growth

Autism Disorder and Treatment Market – Overview

Autism cases have been on the rise in the recent years, but the treatment options for the ailment are few and not effective enough to combat the disease. Market reports linked to the healthcare sector made available by Market Research Future along with published reports on other sectors have been recently published along with a report on this market. The industry is anticipated to grow at a CAGR of 4.37 percent in the forecast period.

Availability of better detection and diagnostic facilities have increased the industry scope for autism treatment. Increased funding for medical research and development purposes have raised the opportunities for development of drugs and treatment options of autism. Heightened levels of awareness of autism have increased the investment level for the expansion of the industry which will continue through the review period till 2023.

Get Sample Report:

Industry Segments

The Autism Disorder and Treatment Market Size has been segmented on the basis of treatment type, type and drugs.

By type the market is segmented into the segments of Pervasive Developmental Disorder, Asperger Syndrome, and others.

The treatment type segment of the autism disorder and treatment industry is segmented into hyperbaric oxygen therapy ABA (applied behavioral analysis), chelation therapy and oxytocin therapy among others.

Lastly on the basis of drugs, the industry segmented into anti-psychotic, anti-convulsant, SSRIs, stimulants. The Anti-psychotics segment is additionally segmented Risperidone and into Abilify (aripiprazole).

Key Companies: Eli Lilly and Company, Allergan, Consern Pharma Private Limited, Merck & CO Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Bristol-Myers Squibb, Johnson & Johnson Services, Inc., Otsuka Holdings Co., Ltd and Coronis Partners Ltd are a few of the important players in the market.

Detailed Regional Analysis

The autism disorder & treatment industry globally is segmented into the following regions such as Europe, Americas, Asia Pacific, the Middle East and Africa. The Americas hold the major market portion followed by the European region. In the Americas region, the North American region is the largest regional market owing to the growing screening of autism cases in this particular region. Moreover, the expected launch and approval of the atypical anti-psychotics such as Namenda and Latuda is estimated to lead to better sales in the U.S. after approval. The Asia Pacific region is estimated to be the most rapidly developing regional market while the Middle East & African region has demonstrated stable growth during the forecast period. With increased detection of autism disorder cases around the world, the industry will be prompted to grow in response so as to treat and control this particular ailment.

Global Competitive Analysis

Contenders who are a part of the industry have devised their corporate strategy blueprint in a way that that can bring the best outcomes for development in the current scenario. With the ability to sustain their competitive edge being one of the primary factors driving their efforts, the scope for growth in the industry appears to be promising through the forecast period. The rising affinity for diversification in the market, has indirectly enabled the players to utilize the many prospects available. This specific trend has enabled portfolio improvements along with the affinity for diversification in the sector, which has helped the market competitors tremendously in this industry. The companies in this particular industry are also trying to maintain and enhance financial liquidity that can be instrumental to invest in growth strategies as and when they become available.

Industry Updates:

Mar 2018 A path breaking drug that addresses the root causes of autism could be accessible in the UK within five years because initial trial results for Balovaptan have fascinated US regulators, that the drug has been given an “accelerated status”, making way for faster approval. The cure which has been developed by the drug giant Roche acts as a brain receptor for the hormone vasopressin, which is understood to have influence on social bonding. The trial spanned over a time period of 12-weeks which comprised of 223 men in which one group had the placebo and the other group had the treatment. Individuals who took the drug scored significantly higher on social behavioral scales.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Dry Age-Related Macular Degeneration Market

This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments.

It has been estimated that the Dry Age-Related Macular Degeneration Market Size has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.

List of Key Companies Covered in this report:

Santen Pharmaceuticals Inc. (Japan), Allergan plc (Ireland), Bausch Health (Canada), Alimera Science Inc. (US), Phio Pharmaceuticals Corp (US), Ocumension Therapeutics Co. Ltd (China), Belite Bio Inc. (US), Kubota Vision Inc. (US), Iveric Bio (US), Eyestem Research Pvt Ltd (India), Yuyang DNU Co., Ltd (South Korea), Stealth Biotherapeutics Inc. (US)

Segment Analysis

The global dry AMD market has been divided based on stages, age group, route of administration, diagnosis& treatment, and end user.

The market, based on stages, has been segregated into early age-related macular degeneration, intermediate age-related macular degeneration, and late age-related macular degeneration.

Based on age group, the dry AMD market has been divided into above 75 years, above 60 years, and above 40 years.

Based on diagnosis & treatment, the dry AMD market has been divided into treatment and diagnosis.

Treatment type is further bifurcated into nutrition therapy and telescopic lens implant. Nutrition therapy is again divided into antioxidants and others. Antioxidants areal so segregated as vitamins, zinc, copper, omega-3 fatty acids, and others.

Diagnosis is bifurcated into fluorescein angiogram, preliminary test, optical coherence tomography, and others.

Based on route of administration, the market is bifurcated into oral, intravitreal, and others.

On the basis of end user, the market is bifurcated into hospitals and clinics, diagnostic centers, academic research institutes, and others

Dry Age-Related Macular Degeneration Market Size

AMD has projected a rise from $ 1.58 billion in 2020 to $ 2.64 billion in 2026. The CAGR rate is expected to grow exponentially between 2021 to 2018 – 8.93%.

Dry Age-Related Macular Degeneration Market Share

It has been reported by the American Academy of Ophthalmology that about 11 million people over the age of fifty experience blindness as a result of AMD. Hence making it a supple market for AMD related treatments. Obesity-related macular degeneration is also on the rise in North America, along with high blood pressure from an erratic lifestyle.

Advances in research and development in Europe and Asia-Pacific have enabled more patients to see more clearly. The African continent, particularly the Sahara subcontinent, has experienced a significant increase in dry age-related macular degeneration due to lack of vitamin A and poor dietary standards. Thus, making this region the key player for pharmaceutical companies to invest in.

The key companies that are invested into creating feasible solutions for AMD are Pfizer, Bayer AG, Regenron Pharmaceutical Inc., GlaxoSmithKline plc, and Novartis AG.

Dry Age-Related Macular Degeneration Market Growth

The AMD market is led by dry and wet drug solutions that treat this degenerative disease. Wet age-related AMD will soon see a jump of 95% in the year 2022. After the impact of COVID-19, it has been observed that wet macular degeneration has affected most of the ageing population. In this type, there is an atypical growth of blood vessels beneath the retina, causing it to bleed create vision obstruction. Developed countries have introduced intraocular anti-VEGF injections for patients suffering from wet AMD, thus increasing treatment capacity globally.

In recent years, Stargardt disease, a genetically inherited retinal disorder that has become dominant among the younger population, has given impetus for research towards macular degeneration drugs.

Lucentis, Avastin, Eylea and Visudyne are some of the prominent drugs available in the market to treat dry age-related macular degeneration. The Lucentis market has grown rapidly in developed countries since the government introduced healthcare benefits for the elderly through affordable treatments.

Dry Age-Related Macular Degeneration Market Value

It has been noted that off-label drugs are getting more popular due to their affordability than on-label drugs to treat AMD. An off-label drug like Avastin is sold rapidly in the market for patients who can get treated within their income budget.

On a case-by-case basis, the market is segmented into intravenous and intravitreous. It is said that the intravitreal segment dominates the market because it is most effective because of the targeted distribution of drugs. Furthermore, the majority of anti-VEGF injections are given intravitreally or intraocular.

Industry News

Recent data released by the World Bank statistics indicate that the older generation living above 65% is rising. They represent approximately 8.873% of the population, indicating that patients with AMD will increase due to chronic diseases and diseases.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Medical Ventilator Market -Overview

The spread of COVID infection has emerged as the primary element compelling demand. The revival of cases in some locations is anticipated to push its use even more into the medical ventilator market projected timeframe. The portable medical ventilator market is anticipated to be transformed as a part of government assistance in the form of expedited approvals and subsidies. As per MRFR, the market is estimated to utilize a CAGR of 4.14% to touch USD 3,605.82 Million by 2027.

Numerous Mechanical Ventilators Market players are inventing ventilator designs to assist primary caregivers in sustaining a safe distance from patients while dealing with mounting patient numbers. The emergence of diversified and effective products to address the particular problems of the ongoing crisis is projected to push the medical ventilator market share.

The central players in the medical ventilators market: -

Vyaire Medical, Inc. (US), Koninklijke Philips NV (Netherlands), Drägerwerk AG Co. KGaA (Germany), Smiths Medical (US), Medtronic (Ireland), GE Healthcare (US), Hamilton Medical (Switzerland), Getinge AB (Sweden), Resmed (US), and Allied Healthcare Products Inc. (US).

Segmental Analysis

The segmental appraisal of the portable ventilators market is conducted based on portability, technology, application, end-user, and region.

The medical ventilator market's application segment includes emergency care, neonatal care, and critical care. Europe, MEA, Africa, and the Asia Pacific are represented in the medical ventilator market. Mechanical and automated medical ventilators are the two technology segments of the medical ventilator market.

The medical ventilator market's end-user portability category is divided into home care settings and hospitals clinics. The medical ventilator market is divided into two interface segments: non-invasive and invasive. The medical ventilator market's portability segment is divided into stationary and portable ventilators.

Detailed Regional Analysis

The regional review of the medical ventilator market includes the MEA, Africa, Europe, and the Asia-Pacific. Due to the product releases, enormous frequency of respiratory illnesses, and the procurement of new resources in the regional market, the Americas region led the medical ventilator market and is anticipated to maintain its domination throughout the forecast period. The improved prevalence of respiratory illnesses resulting from the pandemic's spread in the Americas region will consolidate the region's lead. The Asia Pacific medical ventilator market is expected to grow at the fastest rate in the projected period, owing to the advanced occurrence of COVID-19 cases and product endorsements, which would back the ventilators market's growth. The medical ventilator market in the Middle East and Africa is projected to grow steadily. Due to a spike in COVID-19 cases in the Middle Eastern region, medical ventilators have escalated in national markets like the UAE, South Africa, and Saudi Arabia. With more planned tenders being launched by private and public businesses, the expansion rate will intensify in the future years.

Competitive Analysis

Government assistance is expected to support worldwide market development in the next years. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Market developments and research are expected to generate attractive growth opportunities in the next years. The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth. Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Market Forecast

Market Research Future (MRFR) assessed the worldwide dental chair market 2020 across the assessment period till 2025. Across 2019 to 2025, the dental chair market can expand at 4.1% CAGR. By 2025, the dental chair market value can touch of about USD 627.1 Mn. Advancements in functionality of dental chairs is a potential factor that is instrumental to the upsurge of dental chair market. The rise in attention towards comfort of patient undergoing dental procedures can boost sales of modern sitting technology can favour expansion of the dental chair market in the review period. The increase in cases of dental surgeries and the availability of different type of dental chairs to meet patient demands can also contribute to the expansion of the market in the near future.

The growing traction for powered dental chairs due to their better flexibility, advanced lighting system, and attached radiology scanner can promote expansion of the market in the analysis period. In addition, improved medical technology can promote market expansion in the review period. High price and low capital can hinder Dental Chair Market rise.

Key Players

PLANMECA OY, Dentsply Sirona, Henry Schein, Inc., A-dec Inc., Danaher Corporation, Patterson Dental Supply, Inc., KaVo Dental GmbH, XO CARE A/S, Midmark, and Craftmaster Contour Equipment, Inc are some reputed names in the worldwide dental chair company that are listed by MRFR.

Market Segmentation

The segment analysis of the global dental chair market is based on product, application, and type.

The product-based segments of the dental chair market are powered dental chairs and non-powered dental chairs. Powered dental chairs are expensive, thus non-powered chairs are used extensively. However, the increase in awareness about several benefits of powered chairs is gaining it traction that can also favor the market expansion in the approaching years.

The Type-based segments of the dental chair market are Fixed Dental Chair and Portable Dental Chair. The portable dental chair segment can win decent market share on conclusion of the evaluation period.

The application-based segments of the dental chair market are oral surgery, orthodontics, and oral surgery among other. The oral surgery segment can thrive in the analysis period.

Regional Study

The dental chair market in the Americas can be led by the US by and Canada have been at the forefront of the healthcare industry over the years. The growing count of dentists and increase in cases of dental examinations can support expansion of the regional market. Development of innovative products and rise in demand for prosthodontics, along with increase in active dental issues cases can boost expansion of the dental chair market in the review period. The rise in awareness about several oral health solutions can support the Americas market expansion.

In Europe, the dental chairs market can thrive due to the presence of well-established dental industry and surge in number of dental product manufacturers. The surge in cases of oral surgeries can cause the UK market to rise at decent CAGR.

In Asia Pacific, the dental chair market expansion can be attributed to growing demand for effective dental procedures, increase in number of dental care providers, escalation in the per capita disposable incomes, and rapidly developing healthcare infrastructure. The rise in dental tourism market in Asian countries can also support rise of the market.

In Middle East and Africa, the market is expected to experience resistance due to limited healthcare facilities and lack of cognizance about oral hygiene. However, increase in capita disposable income can counter regional market slow-down as developing economy can support modern medical facilities.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Market Highlights

According to MRFR analysis, Healthcare Data Storage Market is expected to register a CAGR of 13.9% during the forecast period of 2019 to 2025 and is likely to be valued at USD 48.2 Billion in 2025.

Healthcare data storage are software solutions used by hospitals, clinics, diagnostic centers to store patient data for future use. These solutions are used by healthcare companies to store data about manufacturing products and their processes.

The growth of the global Healthcare Data Storage Market is determined by numerous factors such as an increasing patient database due to the increasing number of surgeries, increasing clinical trials, and research activities to develop innovative products. Also, the decreasing paper use to maintain patient information increases the demand for healthcare data storage solutions. However, the key factors such as data infringement, cyber-attacks and high cost of healthcare data storage solution hamper the market growth.

Segmentation

The Global Healthcare Data Storage Market has been segmented based on solution, application, architecture, type, storage system, and end user.

The market, based on solution, has been divided into on-premises, cloud, and hybrid data storage. On-premises is likely to hold the maximum market share in the global healthcare data storage market.

The Global Healthcare Data Storage Market based on application has been segregated into the clinical analysis, financial analysis, and operational analysis. The clinical analysis segment is expected to hold a larger share of the market share owing to the rising number of hospitals, clinics, and diagnostic centres. Clinical analysis is further sub-segmented into clinical decision support, quality control, reporting and compliance, population health management, and precision health. The financial analysis is further segmented into revenue cycle management, claim processing, risk adjustment & assessment, and others.

On the basis of architecture is segmented into file storage, object storage, and block storage.

Based on type, the market is segmented into flash & solid-state storage and magnetic storage. The magnetic storage is further sub-segmented into magnetic disks and magnetic tapes. On the basis of storage system, the market is segmented into storage area network and network-attached storage direct-attached storage.

The end user segment of the market consists of hospitals and clinics, pharmaceutical & biotechnology companies, clinical/contract research organizations (CROs), and contract manufacturing organizations (CMOs), and others.

Key Players

Some of the Key Players in the Global Healthcare Data Storage Market are Data Core Software (US), Dell Inc. (US), IBM Corporation (US), NetApp (US), Hewlett Packard Enterprise (HPE)(US), Pure Storage (US), Hitachi (Japan), Western Digital (US), Nuance Communications, Inc (US), and Carestream Corporation (US).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the increasing burden of clinical data, which is challenging to handle drives the market growth during the forecasted period.

The European healthcare data storage market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Italy, Germany, Spain, France, the UK, and the rest of Western Europe. The healthcare data storage market in Asia-Pacific has been segmented into Japan, India, China, Australia, South Korea, and the rest of Asia-Pacific. Due to the rising geriatric population and the presence of a large patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The healthcare data storage market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future®

99 Hudson Street,5Th Floor

New York, New York 10013

United States of America

Phone:

+1 628 258 0071(US)

+44 2035 002 764(UK)

Patient engagement solutions are a range of methods used by healthcare authorities to communicate with patients in a transparent manner. The advent of digital technology and its ability to reach a wide audience has widened the opportunity for patient satisfaction. The global patient engagement solutions market report by Market Research Future (MRFR) takes a deeper look at the changing landscape of the healthcare sector and implementation of new policies for enhancing patient care for the period of 2019 to 2025 (forecast period). The sudden outbreak of the COVID-19 pandemic and its impact on the industry has been noted and expounded in great detail.

Market Scope

The global Patient Engagement Solutions Market is expected to exceed a value of USD 42,600 million by 2025. It can expand at a CAGR of 18.90% over the forecast period.

Investments in the healthcare sector, focus on patient care, and expansion plans of hospital chains are major drivers of the market. Rising prevalence of chronic diseases has induced the need for solutions which can lower the burden on healthcare chains and patients. In 2016, chronic diseases such as cancer, diabetes, and obesity had affected close to 117 million Americans. Government initiatives advocating the use of digital data and its centralization can favor the patient engagement software solutions market growth.

But initial high investments can deter new players from entering the market and deter its growth.

Competitive Outlook

IBM, Allscripts Healthcare Solutions, Inc., Oneview Ltd, Orion Health Ltd, Cerner Corporation, Welvu, McKesson Corporation, Get Real Health, Lincor Solutions, Medecision, Inc., Athenahealth, Inc., and Aetna Inc. are key players of the global patient engagement solutions market.

Segmentation

The global patient engagement solutions market is segmented by component, delivery mode, therapeutic are, application, and end-user.

By component, it is segmented into hardware, software, and services. Patient engagement software is the largest segment due to its ability to provide accurate, unbiased, and relevant data. Furthermore, its link to electronic health records of patients can fetch relevant data for physicians and clinicians for faster diagnosis. The hardware segment is expected to hold the least market share in the patient engagement solution market. It is used for building and support patient engagement platforms.

By delivery mode, it is segmented into on-premise, web-based, and cloud-based. The cloud-based segment is the largest in the market owing to easy installation of cloud-based software and easy access by users through the Internet. This model works similar to the on-premise model. On the other hand, the on-premise model of delivery is installed within the premises of the organization and can be maintained at ease. But its maintenance costs can lead to hesitation among end-users

By therapeutic area, it is segmented into fitness management, women’s health management, chronic disease, and others.

The chronic disease segment is expected to maintain its lead over the forecast period. Rising prevalence of chronic diseases and increasing awareness about patient engagement solutions can curry favor for the growth of this segment. The fitness management segment is the fastest-growing and anticipated to register the highest CAGR during the forecast period.

By application, it is segmented into financial health management, home health management, health management, and social management.

By end-user, it is segmented into individual users, healthcare payers, hospitals and healthcare providers, and others. ‘Others’ comprise emergency centers, government organizations, small- and mid-scale healthcare centers, and others.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are regions considered for the prospects of the global patient engagement solutions market.

The Americas is the largest regional market. An implementation of incentives to shift the burden of risk from healthcare payers to providers and rising insurance holders is likely to drive the growth of the market during the assessment period. According to MRFR analysis, the percentage of people with health insurance coverage in 2017 was 91.2%. Rise in the number of people opting for health insurance can fuel the regional patient engagement solutions market.

APAC is the fastest-growing regional market for patient engagement solutions owing to the largest population and a fast-developing healthcare sector. Investments in modernizing healthcare infrastructure, cases of chronic diseases, and medical tourism can influence the market. Moreover, East Asia has a growing geriatric population which is directly associated with an increasing number of healthcare procedures, and it is anticipated to drive the growth of the market.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Increasing Prevalence of Hearing Disorders Fuels the Growth of Global Hearing Aids Market

The hearing aid is a battery-powered electronic device intended to enhance hearing capacity. The global market for hearing aids is estimated to expand at a lucrative rate over the forecast period. This can be ascribed to critical factors such as increasing the use of these devices, raising awareness of technologically advanced devices for the treatment of deafness, and growing prevalence of hearing loss due to the rising geriatric population.

As per Market Research Future (MRFR) analysis, the global Hearing Aids Market is expected to reach USD 8.0 billion with a CAGR of 7.0% from 2019 to 2025 (forecast period).

Market Dynamics

The growing geriatric population around the globe is one of the major factors driving the market growth. There has been a substantial rise in the prevalence of hearing disorders among the population. In addition, the introduction of aesthetically appealing designs, combined with the launch of innovative product variations, like waterproof hearing aids, also contributes to the growth of the industry. The adoption of emerging technologies, combined with the launch of products that incorporate cochlear implant and hearing aid technology to address high-frequency hearing loss, is expected to establish a positive consumer outlook further.

Other factors such as, increasing cases of birth complications and ear infections, rising noise pollution levels, increasing disposable income, and increased focus on research and development (R&D) by manufacturers are also expected to boost the market growth.

Segmentation

The global market for hearing aids has been segmented into product, product type, type of hearing loss, technology type, distribution channel, and region.

Based on the product, the global market for hearing aids has been segmented into devices, Implants, and accessories. Among these, the device segment holds the largest market share.

Based on product type, the global market for hearing aids has been segmented into wireless and wired. The wireless segment contributes the most significant market share and also the fastest-growing segment.

Based on the type of hearing loss, the global market for hearing aids has been segmented into sensorineural, conductive, and others.

Based on the type of technology, the global market for hearing aids has been segmented into digital hearing, aids, analog hearing aids. The digital hearing segment accounts for the largest market share and is the fastest-growing segment.

Based on the distributional channel, the global market for hearing aids has been segmented into retail stores, e-commerce, and others.

Key players

Some of the major participants in the global hearing aids market are Sonova (Switzerland), Cochlear LTD (Australia), GN Store Nord A/S (Denmark), Sivantos PTE. LTD (Singapore), Arphi Electronic PVT (India), Demant AS (Denmark), Starkey Technologies (US), Micrson (Spain).

Region-wise, the global hearing aids market has been segmented into Europe, the Americas, the Asia Pacific, and the Middle East & Africa.

Europe led the market in 2018 with a revenue of USD 2.2 billion and is projected to rise at a lucrative pace over the forecast period. Increased prevalence of hearing loss and increased awareness of technological advances are key factors driving demand for these devices in Europe. In addition, the growth of the market for audiology devices in this region depends on each European nation's policies for reimbursement. According to the European Federation of Hard of Hearing People, about 51 million people in the European Union had deafness in 2015. There are 11 million people in the U.K. who experience hearing loss. Due to the increase in the aging population in Europe, hearing impairment is expected to increase, which in turn is anticipated to drive the market in Europe.

The Asia Pacific market is expected to see the fastest growth in the forecast period due to a large population base, an increase in the prevalence of the geriatric population and a development in the distribution network of global market players. Market leaders are continuously developing advanced products that enhance the benefits of these devices to target consumers and drive the acceptance of these devices in the region. Other market-driven factors in the Asia Pacific include rising disposable income and healthcare expenditure of the general population, combined with government initiatives.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013